Clinical Trials Directory

Trials / Completed

CompletedNCT02229591

Expiratory Flow Limitation and Postoperative Complications

Status
Completed
Phase
Study type
Observational
Enrollment
330 (actual)
Sponsor
Università degli Studi di Ferrara · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Expiratory flow limitation (EFL) occurs when flow ceases to increase with increasing expiratory effort. In any circumstances EFL predisposes to pulmonary dynamic hyperinflation and its unfavorable effects such as increased elastic work of breathing, inspiratory muscles dysfunction, and progressive neuroventilatory dissociation, leading to reduced exercise tolerance, marked breathlessness during effort, and severe chronic dyspnea. Our hypothesis is that EFL should affect post operative outcomes like incidence of pulmonary complication and length of stay in hospital

Conditions

Timeline

Start date
2013-01-01
Primary completion
2016-08-01
Completion
2016-09-01
First posted
2014-09-01
Last updated
2016-10-26

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT02229591. Inclusion in this directory is not an endorsement.